Current GMP standards for the large‐scale production of monoclonal antibodies

Understanding pharmaceutical quality by design

Yu, L. X., Amidon, G., Khan, M. A., Hoag, S. W., Polli, J., Raju, G. K., & Woodcock, J. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9598-3 · Cited by 1,475 · see citing works

Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control

Yu, L. X. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9511-1 · Cited by 1,192 · see citing works

Monoclonal Antibodies in Cancer Therapy

Zahavi, D. J., & Weiner, L. M. (2020) · Antibodies · doi:10.3390/antib9030034 · Cited by 845 · see citing works

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants

Griffin, M. P., Yuan, Y., Takas, T., Domachowske, J. B., Madhi, S. A., Manzoni, P., Simões, E. A. F., Esser, M. T., Khan, A. A., Dubovsky, F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1913556 · Cited by 778 · see citing works

Cell culture processes for monoclonal antibody production

Li, F., Vijayasankaran, N., Shen, A. (., Kiss, R., & Amanullah, A. (2010) · mAbs · doi:10.4161/mabs.2.5.12720 · Cited by 739 · see citing works

Industrialization of mAb production technology: The bioprocessing industry at a crossroads

Kelley, B. D. (2009) · mAbs · doi:10.4161/mabs.1.5.9448 · Cited by 668 · see citing works

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

Salles, G., Barrett, M., Foà, R., Maurer, J., O'Brien, S. M., Valente, N., Wenger, M., & Maloney, D. G. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0612-x · Cited by 620 · see citing works

Recovery and purification process development for monoclonal antibody production

Liu, H. F., Ma, J., Winter, C., & Bayer, R. J. (2010) · mAbs · doi:10.4161/mabs.2.5.12645 · Cited by 561 · see citing works

Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 499 · see citing works

Mammalian cell protein expression for biopharmaceutical production

Zhu, J. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.08.022 · Cited by 492 · see citing works

Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives

Dumont, J., Euwart, D., Mei, B., Estes, S., & Kshirsagar, R. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1084266 · Cited by 483 · see citing works

Future of antibody purification

Low, D. K. R., O'Leary, R. M., & Pujar, N. S. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.10.033 · Cited by 472 · see citing works

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer’s Disease

Cummings, J. L., Osse, A. M. L., Cammann, D., Powell, J., & Chen, J. (2023) · BioDrugs · doi:10.1007/s40259-023-00633-2 · Cited by 396 · see citing works

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants

Drysdale, S. B., Cathie, K., Flamein, F., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2309189 · Cited by 392 · see citing works

NANOBODIES®: A Review of Diagnostic and Therapeutic Applications

Jin, B.-K., Odongo, S., Radwanska, M., & Magez, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065994 · Cited by 387 · see citing works

A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants

Zhu, Q., McLellan, J. S., Kallewaard, N. L., Ulbrandt, N. D., Palaszynski, S., Zhang, J., Moldt, B., Khan, A. A., Svabek, C., McAuliffe, J. M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaj1928 · Cited by 363 · see citing works

Therapeutic monoclonal antibodies

Breedveld, F. C. (2000) · The Lancet · doi:10.1016/s0140-6736(00)01034-5 · Cited by 361 · see citing works

PCSK9 inhibitors: A new era of lipid lowering therapy

Chaudhary, R., Garg, J., Shah, N., & Sumner, A. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i2.76 · Cited by 299 · see citing works

Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review

Chen, Y., Yang, O., Sampat, C., Bhalode, P., Ramachnadran, R., & Ierapetritou, M. (2020) · Processes · doi:10.3390/pr8091088 · Cited by 295 · see citing works

Antibody regulation of B cell development

Meffre, E., Casellas, R. C., & Nussenzweig, M. C. (2000) · Nature Immunology · doi:10.1038/80816 · Cited by 280 · see citing works

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside

Alfaleh, M. A., Alsaab, H. O., Mahmoud, A. B., Alkayyal, A. A., Jones, M. L., Mahler, S. M., & Hashem, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01986 · Cited by 280 · see citing works

Anti-TNF Therapy in Crohn’s Disease

Adegbola, S. O., Sahnan, K., Warusavitarne, J. H., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082244 · Cited by 277 · see citing works

Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments

de Mattos, B. R. R., Garcia, M. P. G., Bier, J., Paiatto, L. N., Albuquerque, C. G., Souza, C. L., Fernandes, L. G. R., Tamashiro, W. M. D. S. C., & Simioni, P. U. (2015) · Mediators of Inflammation · doi:10.1155/2015/493012 · Cited by 257 · see citing works

Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired

Marei, H. E. S., Hasan, A., Pozzoli, G., & Cenciarelli, C. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02902-0 · Cited by 257 · see citing works

Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives

Parray, H. A., Shukla, S., Samal, S., Shrivastava, T., Ahmed, S., Sharma, C., & Kumar, R. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106639 · Cited by 225 · see citing works

Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting

Wattiez, A., Sowers, L. P., & Russo, A. F. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1724285 · Cited by 221 · see citing works

The role of inflammation in autoimmune disease: a therapeutic target

Xiang, Y., Zhang, M., Jiang, D., Su, Q., & Shi, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1267091 · Cited by 205 · see citing works

Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years

Alexander, E., & Leong, K. W. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02900-y · Cited by 203 · see citing works

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Marshall, M. J. E., Stopforth, R. J., & Cragg, M. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01245 · Cited by 184 · see citing works

Effects of ammonia and lactate on growth, metabolism, and productivity of BHK cells

Cruz, H. J., Freitas, C., Alves, P. M., Moreira, J. L., & Carrondo, M. J. T. (2000) · Enzyme and Microbial Technology · doi:10.1016/s0141-0229(00)00151-4 · Cited by 182 · see citing works

Biosimilars: Key regulatory considerations and similarity assessment tools

Kirchhoff, C. F., Wang, X. M., Conlon, H. D., Anderson, S., Ryan, A. M., & Bose, A. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26438 · Cited by 181 · see citing works

Hybridoma technology; advancements, clinical significance, and future aspects

Mitra, S., & Tomar, P. C. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00264-6 · Cited by 181 · see citing works

Using Residence Time Distributions (RTDs) to Address the Traceability of Raw Materials in Continuous Pharmaceutical Manufacturing

Engisch, W. E., & Muzzio, F. J. (2015) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-015-9238-1 · Cited by 171 · see citing works

Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products

Bretaudeau, L., Tremblais, K., Aubrit, F., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01161 · Cited by 120 · see citing works

Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions

Abdeldaim, D. T., & Schindowski, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102402 · Cited by 114 · see citing works

Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative Colitis

Feagan, B. G., Sandborn, W. J., Lazar, A., Thakkar, R. B., Huang, B., Reilly, N., Chen, N., Yang, M., Skup, M., Mulani, P. M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.032 · Cited by 108 · see citing works

Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials

Li, B., Jin, J., Guo, D., Tao, Z., & Hu, X. (2023) · Cancers · doi:10.3390/cancers15102858 · Cited by 106 · see citing works

Comparison between Batch and Continuous Monoclonal Antibody Production and Economic Analysis

Yang, O., Prabhu, S., & Ierapetritou, M. (2019) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.8b04717 · Cited by 105 · see citing works

Analytical Techniques for the Characterization and Quantification of Monoclonal Antibodies

Alhazmi, H. A., & Albratty, M. (2023) · Pharmaceuticals · doi:10.3390/ph16020291 · Cited by 105 · see citing works

Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation

Sifniotis, V., Cruz, E., Eroglu, B., & Kayser, V. (2019) · Antibodies · doi:10.3390/antib8020036 · Cited by 99 · see citing works

Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume

Desai, M. G., Kundu, A., Hageman, M., Lou, H., & Boisvert, D. (2023) · mAbs · doi:10.1080/19420862.2023.2285277 · Cited by 92 · see citing works

Trop2-targeted therapies in solid tumors: advances and future directions

Liu, X., Ma, L., Li, J., Sun, L., Yang, Y., Liu, T., Xing, D., Yan, S., & Zhang, M. (2024) · Theranostics · doi:10.7150/thno.98178 · Cited by 89 · see citing works

Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs

Abou-El-Enein, M., Römhild, A., Kaiser, D., Beier, C., Bauer, G., Volk, H.-D., & Reinke, P. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2012.09.006 · Cited by 86 · see citing works

Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies

Singh, R. K., Chandley, P., & Rohatgi, S. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2300102 · Cited by 86 · see citing works

Determination of the maximum operating range of hydrodynamic stress in mammalian cell culture

Neunstoecklin, B., Stettler, M., Solacroup, T., Broly, H., Morbidelli, M., & Šoóš, M. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.12.003 · Cited by 78 · see citing works

Ribosome display: Cell-free protein display technology

He, M. (2002) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/1.2.204 · Cited by 77 · see citing works

Blockchain technology: A potential tool for the management of pharma supply chain

Akram, W., Joshi, R., Haider, T., Sharma, P., Jain, V. K., Garud, N., & Singh, N. K. (2024) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2024.02.014 · Cited by 77 · see citing works

Practical Guidance for Clinical Microbiology Laboratories: Implementing a Quality Management System in the Medical Microbiology Laboratory

Carey, R. B., Bhattacharyya, S., Kehl, S. C., et al. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00062-17 · Cited by 74 · see citing works

Assurance of monoclonality in one round of cloning through cell sorting for single cell deposition coupled with high resolution cell imaging

Evans, K., Albanetti, T., Venkat, R. V., Schoner, R. G., Savery, J., Miró-Quesada, G., Rajan, B., & Groves, C. (2015) · Biotechnology Progress · doi:10.1002/btpr.2145 · Cited by 70 · see citing works

A Comprehensive Review of Monoclonal Antibodies in Modern Medicine: Tracing the Evolution of a Revolutionary Therapeutic Approach

Kothari, M., Wanjari, A., Acharya, S., et al. (2024) · Cureus · doi:10.7759/cureus.61983 · Cited by 70 · see citing works

Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance

Sardella, M., Belcher, G., Lungu, C., et al. (2021) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986211038436 · Cited by 66 · see citing works

Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome

Keating, G. M. (2013) · Drugs · doi:10.1007/s40265-013-0147-7 · Cited by 65 · see citing works

Monoclonal Antibodies as Neurological Therapeutics

Gklinos, P., Papadopoulou, M., Stanulović, V., Mitsikostas, D. D., & Papadopoulos, D. (2021) · Pharmaceuticals · doi:10.3390/ph14020092 · Cited by 62 · see citing works

Protein aggregation and mitigation strategy in low pH viral inactivation for monoclonal antibody purification

Jin, W., Xing, Z., Song, Y., Huang, C., Xu, X., Ghose, S., & Li, Z. J. (2019) · mAbs · doi:10.1080/19420862.2019.1658493 · Cited by 61 · see citing works

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature

Chatziralli, I., & Loewenstein, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081137 · Cited by 59 · see citing works

The Structure of Natural and Recombinant Antibodies

Ma, H., & O’Kennedy, R. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2999-3_2 · Cited by 58 · see citing works

New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-Making

Gerischer, L. M., Doksani, P., Hoffmann, S., & Meisel, A. (2025) · BioDrugs · doi:10.1007/s40259-024-00701-1 · Cited by 56 · see citing works

Introduction to the application of QbD principles for the development of monoclonal antibodies

Finkler, C., & KRUMMEN, L. A. (2016) · Biologicals · doi:10.1016/j.biologicals.2016.07.004 · Cited by 55 · see citing works

FcRn inhibitors: a novel option for the treatment of myasthenia gravis

Wu, J., Zhu, L., Hou, H., Wang, S., Zhang, S., Wang, G., & Guo, Z. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.363824 · Cited by 55 · see citing works

Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU)., Iborra, M., Gisbert, J. P., Boscá-Watts, M. M., López‐García, A., García-Sánchez, V., López–Sanromán, A., Hinojosa, E., Márquez, L., García‐López, S., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1293-y · Cited by 52 · see citing works

Current GMP standards for the production of vaccines and antibodies: An overview

Covarrubias, C., Rivera, T., Soto, C. A., Deeks, T., & Kalergis, A. M. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1021905 · Cited by 52 · see citing works

Minimizing the Immunogenicity of Antibodies for Clinical Application

Gonzales, N. R., Pascalis, R. D., Schlom, J., et al. (2005) · Tumor Biology · doi:10.1159/000084184 · Cited by 51 · see citing works

Ribosome Display Technology: Applications in Disease Diagnosis and Control

Kunamneni, A., Ogaugwu, C., Bradfute, S. B., & Durvasula, R. V. (2020) · Antibodies · doi:10.3390/antib9030028 · Cited by 50 · see citing works

Production of monoclonal antibodies for therapeutic purposes: A review.

Alejandra, W.-P., Irene, J.-P. M., Antonio, G.-S. F., Patricia, R., Elizabeth, T., Pablo, A.-A. J., & Rebeca, G.-V. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110376 · Cited by 50 · see citing works

An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?

Moorkens, E., Vulto, A. G., & Huys, I. (2020) · mAbs · doi:10.1080/19420862.2020.1743517 · Cited by 49 · see citing works

End‐to‐end collaboration to transform biopharmaceutical development and manufacturing

Erickson, J., Baker, J. C., Barrett, S., Brady, C., Brower, M., Carbonell, R. G., Charlebois, T., Coffman, J., Connell‐Crowley, L., Coolbaugh, M. J., et al. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27688 · Cited by 48 · see citing works

Affinity maturation of antibody fragments: A review encompassing the development from random approaches to computational rational optimization

Li, J., Kang, G., Wang, J., Yuan, H., Wu, Y., Meng, S., Wang, P., Zhang, M., Wang, Y., Feng, Y., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125733 · Cited by 48 · see citing works

Biologics and biosimilars: what, why and how?

Chan, J. C. N., & Chan, A. T. �. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000180 · Cited by 46 · see citing works

Immune Correlate-Guided HIV Vaccine Design

Alter, G., & Barouch, D. H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.06.012 · Cited by 45 · see citing works

Monoclonal antibody purification and its progression to commercial scale

Chahar, D. S., Ravindran, S., & Pisal, S. S. (2019) · Biologicals · doi:10.1016/j.biologicals.2019.09.007 · Cited by 45 · see citing works

Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study

Ruggenenti, P. L., Marco, F. D., Cortinovis, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261113 · Cited by 44 · see citing works

Potency assays and biomarkers for cell-based advanced therapy medicinal products

Capelli, C., Cuofano, C., Pavoni, C., Frigerio, S., Lisini, D., Nava, S., Quaroni, M., Colombo, V., Galli, F., Bezukladova, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186224 · Cited by 42 · see citing works

Phage display technology and its impact in the discovery of novel protein-based drugs

Hutchings, C. J., & Sato, A. K. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2367023 · Cited by 42 · see citing works

Modulating antibody effector functions by Fc glycoengineering

García-Alija, M., Moer, B. V., Sastre, D. E., Azzam, T., Du, J. J., Trastoy, B., Callewaert, N., Sundberg, E. J., & Guerin, M. E. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108201 · Cited by 41 · see citing works

Phage Display: A Powerful Technology for the Generation of High Specificity Affinity Reagents from Alternative Immune Sources

Finlay, W. J. J., Bloom, L., & Cunningham, O. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-913-0_6 · Cited by 38 · see citing works

Blockchain technology as an enabler of transparency and efficiency in sustainable supply chains

Nwariaku, H. E., Fadojutimi, B., Lawson, L. G. L., et al. (2024) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2024.12.2.1454 · Cited by 38 · see citing works

Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling

Sachen, K. L., Hammaker, D. R., Sarabia, I., Stoveken, B., Hartman, J., Leppard, K. L., Manieri, N. A., Bao, P., Greving, C. N. A., Lacy, E. R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1532852 · Cited by 38 · see citing works

Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

Habib, A. A., Zhao, C., Aban, I., França, M. C., José, J. G., zu Hörste, G. M., Klimiec, E., Pulley, M., Tavolini, D., Krumova, P., et al. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00514-3 · Cited by 37 · see citing works

Expression of mammalian proteins for diagnostics and therapeutics: a review

Mark, J. K. K., Lim, C. S. Y., Nordin, F., & Tye, G. J. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07651-3 · Cited by 33 · see citing works

A Comprehensive Review About the Use of Monoclonal Antibodies in Cancer Therapy

Justiz-Vaillant, A. A., Pandit, B. R., Unakal, C. G., Vuma, S., & Akpaka, P. E. (2025) · Antibodies · doi:10.3390/antib14020035 · Cited by 33 · see citing works

Next generation and biosimilar monoclonal antibodies: Essential considerations towards regulatory acceptance in Europe; February 3-4, 2011; Freiburg, Germany

Reichert, J. M. (2011) · mAbs · doi:10.4161/mabs.3.3.15475 · Cited by 28 · see citing works

Kinetic modeling of Chinese hamster ovary cell culture: factors and principles

Tang, P., Xu, J., Louey, A., Tan, Z., Yongky, A., Liang, S., Li, Z. J., Weng, Y., & Liu, S. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2019.1711015 · Cited by 26 · see citing works

Anti-CD3 monoclonal antibodies for the prevention and treatment of type 1 diabetes: A literature review

LeFevre, J., Cyriac, S. L., Tokmic, A., & Pitlick, J. M. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac244 · Cited by 22 · see citing works

Perfusion process for CHO cell producing monoclonal antibody: Comparison of methods to determine optimum cell specific perfusion rate

Maria, S., Bonneau, L., Fould, B., Ferry, G., Boutin, J. A., Cabanne, C., Santarelli, X., & Joucla, G. (2022) · Biochemical Engineering Journal · doi:10.1016/j.bej.2022.108779 · Cited by 22 · see citing works

TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target

Condic, M., EGGER, E. K., Klümper, N., Kristiansen, G., Mustea, A., Thiesler, T., & Ralser, D. J. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04761-8 · Cited by 22 · see citing works

Feed development for fed‐batch CHO production process by semisteady state analysis

Khattak, S. F., Xing, Z., Kenty, B. M., Koyrakh, I., & Li, Z. J. (2009) · Biotechnology Progress · doi:10.1002/btpr.362 · Cited by 21 · see citing works

Antibody–drug conjugates and immune checkpoint inhibitors in cancer treatment: a systematic review and meta-analysis

Zhang, L., Yan, Y., Gao, Y., Chen, Y., Yu, J., Ren, N., & Sun, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-68311-z · Cited by 21 · see citing works

Immunosuppressive monoclonal antibodies: current and next generation

Focosi, D., Maggi, F., Pistello, M., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03677.x · Cited by 20 · see citing works

Monitoring Quality Control

Harel, O., Schisterman, E. F., Vexler, A., & Ruopp, M. D. (2008) · Epidemiology · doi:10.1097/ede.0b013e318176bfb2 · Cited by 20 · see citing works

Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells

Boden, E. K., Kongala, R., Hindmarch, D. C., et al. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad224 · Cited by 19 · see citing works

Rapid Microbiology Screening in Pharmaceutical Workflows

Surrette, C., Scherer, B., Corwin, A. D., et al. (2018) · SLAS TECHNOLOGY · doi:10.1177/2472630318779758 · Cited by 18 · see citing works

Evaluating the impact of media and feed combinations on CHO cell culture performance and monoclonal antibody (trastuzumab) production

Gyorgypal, A., Chaturvedi, A., Chopda, V., Zhang, H., & Chundawat, S. P. S. (2025) · Cytotechnology · doi:10.1007/s10616-024-00690-7 · Cited by 17 · see citing works

The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection

Lanari, M., Vandini, S., Arcuri, S., et al. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/359683 · Cited by 16 · see citing works

New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus

Diethelm‐Varela, B., Soto, J. A., Riedel, C. A., Bueno, S. M., & Kalergis, A. M. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s379660 · Cited by 15 · see citing works

Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance

Wu, X., Feng, N., Wang, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1444452 · Cited by 15 · see citing works

Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease

Corti, D., & Kearns, J. D. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.03.001 · Cited by 13 · see citing works

Sacituzumab Govitecan in Triple Negative Breast Cancer: A Systematic Review of Clinical Trials

Pérez-Bermejo, M., Caballero-Pascual, M., Legidos‐Garcia, M. E., Martínez-Peris, M., Mohedo, J. C., Llorca-Colomer, F., Ventura, I., Tomás‐Aguirre, F., Asins-Cubells, A., & Murillo-Llorente, M. T. (2024) · Cancers · doi:10.3390/cancers16213622 · Cited by 13 · see citing works

Tezepelumab improved chronic rhinosinusitis with nasal polyps in a Patient with aspirin exacerbated respiratory disease

Yamashita, Y., Terada, K., Kodama, Y., Nakadegawa, R., Masumitsu, H., Motobayashi, Y., Osada, R., Takayasu, H., Masumoto, N., Kaneko, T., et al. (2024) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2024.102041 · Cited by 10 · see citing works

Functional integration of protein A binding ability to antibody fragments for convenient and tag-free purification

Kuwahara, A., Nazuka, M., Kuroki, Y., et al. (2023) · Bioengineered · doi:10.1080/21655979.2023.2259093 · Cited by 9 · see citing works

Model‐based control system design to manage process parameters in mammalian cell culture for biopharmaceutical manufacturing

Sakaki, A., Tetsushi, N., Nakaya, M., & Ōmasa, T. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28593 · Cited by 9 · see citing works

Dynamics of Pharmaceutical Drugs Serialization

Rajora, N. (2022) · Trends journal of sciences research · doi:10.31586/ujpp.2022.396 · Cited by 8 · see citing works

Analytical Method Validation: A Comprehensive Review of Current Practices

Shinde, S. S., & Khulbe, P. (2025) · South Eastern European Journal of Public Health · doi:10.70135/seejph.vi.6516 · Cited by 8 · see citing works

Scale-up considerations for monoclonal antibody production process: an oxygen transfer flux approach

Giménez, L., Simonet, C., & Malphettes, L. (2013) · BMC Proceedings · doi:10.1186/1753-6561-7-s6-p49 · Cited by 7 · see citing works

Trop2 Expression in Correlation to the Molecular Subtype in Vulvar Squamous Cell Carcinomas

Höhn, A. K., Wolf, B., Forberger, M., et al. (2025) · Pathobiology · doi:10.1159/000543554 · Cited by 6 · see citing works

Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries

Pagliusi, S. R., Madrid, Y., Bramanti, Y., et al. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100366 · Cited by 5 · see citing works

Dimensions of health data Integrity

Lennerz, J. K., Schneider, N., & Lauterbach, K. W. (2024) · European Journal of Epidemiology · doi:10.1007/s10654-024-01106-8 · Cited by 3 · see citing works

Compliance of Pharmaceutical Manufacturing Companies to Good Manufacturing Practices in Heating, Ventilation, and Air‐Conditioning Systems: The Case of Local Ethiopian Firms

Tibesso, D. T., Gabriel, T., Balcha, T., et al. (2024) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/adpp/6109415 · Cited by 3 · see citing works

Monoclonal antibody generation by controlled immunoglobulin gene rearrangements

Murayama, A., Matsui, S., Abe, T., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-07690-z · Cited by 3 · see citing works